The role of oxysterols in control of endothelial stiffness

Journal of Lipid Research

Volumn 53, Issue 7, 2012, Pages 1348-1358

  Shentu, Tzu Pin ^a,b   Singh, Dev K ^a   Oh, Myung Jin ^a   Sun, Shan ^b   Sadaat, Laleh ^a   Makino, Ayako ^a   Mazzone, Theodore ^a   Subbaiah, Papasani V ^a   Cho, Michael ^b   Levitan, Irena ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b University of Illinois at Chicago   (United States)

Author keywords

Atomic force microscopy; Cell stiffness; Cholesterol; Oxidized phosphatidylcholine

Indexed keywords

26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; METHYL BETA CYCLODEXTRIN; OXYSTEROL; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; ATOMIC FORCE MICROSCOPY; BLOOD VESSEL PARAMETERS; CELL ENRICHMENT; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIAL STIFFNESS; LIPID ANALYSIS; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; YOUNG MODULUS;

ANIMALS; APOLIPOPROTEINS E; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; STEROLS;

EID: 84862315127     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M027102     Document Type: Article

References (67)

1. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
2. Witztum, J. L., and D. Steinberg. 2001. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11: 93-102.
3. Stocker, R., and J. F. Keaney, Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84: 1381-1478.
4. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420: 868-874.
5. Paoletti, R., A. M. Gotto, and D. P. Hajjar. 2004. Inflammation in atherosclerosis and implications for therapy. Circulation. 109: III- 20-III-26.
6. Levitan, I., S. Volkov, and P. V. Subbaiah. 2010. Oxidized LDL: diversity, patterns of recognition and pathophysiology. Antioxidants & Redox Signaling. 13: 39-75.
7. Hodis, H. N., D. M. Kramsch, P. Avogaro, G. Bittolo-Bon, G. Cazzolato, J. Hwang, H. Peterson, and A. Sevanian. 1994. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL. J. Lipid Res. 35: 669-677.
8. Holvoet, P., G. Theilmeier, B. Shivalkar, W. Flameng, and D. Collen. 1998. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler. Thromb. Vasc. Biol. 18: 415-422.
9. Cazzolato, G., P. Avogaro, and G. Bittolo-Bon. 1991. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic. Biol. Med. 11: 247-253.
10. van Tits, L. J., T. M. van Himbergen, H. L. Lemmers, J. de Graaf , and A. F. Stalenhoef. 2006. Proportion of oxidized ldl relative to plasma apolipoprotein b does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 185: 307-312.
11. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy , T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
12. Shimokawa, H. 1999. Primary endothelial dysfunction: atherosclerosis. J. Mol. Cell. Cardiol. 31: 23-37.
13. Kinlay, S., P. Libby, and P. Ganz. 2001. Endothelial function and coronary artery disease. Curr. Opin. Lipidol. 12: 383-389.
14. Sima, A. V., C. S. Stancu, and M. Simionescu. 2009. Vascular endothelium in atherosclerosis. Cell Tissue Res. 335: 191-203.
15. Gonzalez, M. A., and A. P. Selwyn. 2003. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am. J. Med. 115(Suppl. 8A): 99S-106S.
16. Heitzer, T., T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 104: 2673-2678.
17. Schächinger, V., M. B. Britten, and A. M. Zeiher. 2000. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary disease. Circulation. 101: 1899-1906.
18. Byfield, F. J., S. Tikku, G. H. Rothblat, K. J. Gooch, and I. Levitan. 2006. OxLDL increases endothelial stiffness, force generation and network formation. J. Lipid Res. 47: 715-723.
19. Shentu, T. P., I. Titushkin, D. K. Singh, K. J. Gooch, P. V. Subbaiah , M. Cho, and I. Levitan. 2010. oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation. Am. J. Physiol. Cell Physiol. 299: C218 -C 229.
20. Kowalsky, G. B., F. J. Byfield, and I. Levitan. 2008. oxLDL facilitates flow-induced realignment of aortic endothelial cells. Am. J. Physiol. Cell. Physiol. 295: C332 -C 340.
21. Levitan, I., and T. P. Shentu. 2011. Impact of oxLDL on cholesterol-rich membrane rafts. J. Lipids. 2011: 730209.
22. Esterbauer, H., J. Gebicki, H. Puhl, and G. Jürgens. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13: 341-390.
23. Itabe, H., M. Mori, Y. Fujimoto, Y. Higashi, and T. Takano. 2003. Minimally modified LDL is an oxidized LDL enriched with oxidized phosphatidylcholines. Journal of Biochemistry. 134: 459-465.
24. Poli, G., B. Sottero, S. Gargiulo, and G. Leonarduzzi. 2009. Cholesterol oxidation products in the vascular remodeling due to atheroslcerosis. Mol. Aspects Med. 30: 180-189.
25. Brown, A. J., and W. Jessup. 1999. Oxysterols and atherosclerosis. Atherosclerosis. 142: 1-28.
26. Deckert, V., L. Persegol, L. Viens, G. Lizard, A. Athias, C. Lallemant , P. Gambert, and L. Lagrost. 1997. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation. 95: 723-731.
27. Leonarduzzi, G., B. Vizio, B. Sottero, V. Verde, P. Gamba, C. Mascia, E. Chiarpotto, G. Poli, and F. Biasi. 2006. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid. Redox Signal. 8: 375-380.
28. Ramasamy, S., G. A. Boissonneault, and B. Hennig. 1992. Oxysterol-induced endothelial cell dysfunction in culture. J. Am. Col. Nutr. 11: 532-538.
29. Lizard, G., M. Moisant, C. Cordelet, S. Monier, P. Gambert, and L. Lagrost. 1997. Induction of similar features of apoptosis in human and bovine vascular endothelial cells treated by 7-ketocholesterol. J. Pathol. 183: 330-338.
30. Panini, S. R., and M. S. Sinensky. 2001. Mechanisms of oxysterol-induced apoptosis. Curr. Opin. Lipidol. 12: 529-533.
31. Moreau, M., I. Brocheriou, L. Petit, E. Ninio, M. J. Chapman, and M. Rouis. 1999. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages. Relevance to stability of atherosclerotic plaque. Circulation. 99: 420-426.
32. Gargiulo, S., B. Sottero, P. Gamba, E. Chiarpotto, G. Poli, and G. Leonarduzzi. 2011. Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: Implications regarding the vulnerability of atherosclerotic lesions. Free Radic. Biol. Med. 51: 844-855.
33. Levitan, I., A. E. Christian, T. N. Tulenko, and G. H. Rothblat. 2000. Membrane cholesterol content modulates activation of volume- regulated anion current (VRAC) in bovine endothelial cells. J. Gen. Physiol. 115: 405-416.
34. Cathcart, M. K., A. K. McNally, and G. M. Chisolm. 1991. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid Res. 32: 63-70.
35. Subbaiah, P. V., V. S. Subramanian, and K. Wang. 1999. Novel physiological function of sphingomyelin in plasma. J. Biol. Chem. 274: 36409-36414.
36. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extractment and purification. Can. J. Biochem. Physiol. 37: 911-917.
37. Allen, R. J. 1940. The estimation of phosphorus. Biochem. J. 34: 858-865.
38. Subbaiah, P. V., D. Sircar, R. S. Lankalapalli, and R. Bittman. 2009. Effect of double bond geometry in sphingosine base on the antioxidant function of sphingomyelin. Arch. Biochem. Biophys. 481: 72-79.
39. Brown, A. J., R. T. Dean, and W. Jessup. 1996. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J. Lipid Res. 37: 320-335.
40. Titushkin, I., and M. Cho. 2007. Modulation of cellular mechanics during osteogenic differentiation of human mesenchymal stem cells. Biophys. J. 93: 3693-3702.
41. Byfield, F. J., H. Aranda-Aspinoza, V. G. Romanenko, G. H. Rothblat , and I. Levitan. 2004. Cholesterol depletion increases membrane stiffness of aortic endothelial cells. Biophys. J. 87: 3336-3343.
42. Byfield, F. J., B. D. Hoffman, V. G. Romanenko, Y. Fang, J. C. Crocker, and I. Levitan. 2006. Evidence for the role of cell stiffness in modulation of volume-regulated anion channels. Acta Physiol. (Oxf.). 187: 285-294.
43. Lenz, M. L., H. Hughes, J. R. Mitchell, D. P. Via, J. R. Guyton, A. A. Taylor, A. M. Gotto, Jr., and C. V. Smith. 1990. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J. Lipid Res. 31: 1043-1050.
44. Dzeletovic, S., A. Babiker, E. Lund, and U. Diczfalusy. 1995. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chem. Phys. Lipids. 78: 119-128.
45. Schuh, J., F. F. Gordon, and R. H. Haschemeyer. 1978. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. USA. 75: 3173-3177.
46. Thorne, S. A., S. E. Abbot, P. G. Winyard, D. R. Blake, and P. G. Mills. 1996. Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart. 75: 11-16.
47. Sigari, F., C. Lee, J. L. Witztum, and P. D. Reaven. 1997. Fibroblasts that overexpress 15-Lipoxygenase generate bioactive and minimally modified LDL. Arterioscler. Thromb. Vasc. Biol. 17: 3639-3645.
48. Bloom, R. J., and J. C. Elwood. 1981. Quantitation of lipid profiles from isolated serum lipoproteins using small volumes of human serum. Clin. Biochem. 14: 119-125.
49. Cuzner, M. L., and A. N. Davison. 1967. Quantitative thin layer chromatography of lipids. J. Chromatogr. 27: 388-397.
50. Björkhem, I., O. Andersson, U. Diczfalusy, B. Sevastik, R. J. Xiu, C. Duan, and E. Lund. 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91: 8592-8596.
51. Crisby, M., J. Nilsson, V. Kostulas, I. Bjökhem, and U. Diczfalusy. 1997. Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques. Biochim. Biophys. Acta. 1344: 278-285.
52. Nakashima, Y., A. S. Plump, E. W. Raines, J. L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14: 133-140.
53. Breslow, J. L. 1996. Mouse models of atherosclerosis. Science. 272: 685-688.
54. Chen, C. S., M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber. 1997. Geometric control of cell life and death. Science. 276: 1425-1428.
55. Sato, M., K. Nagayama, N. Kataoka, M. Sasaki, and K. Hane. 2000. Local mechanical properties measured by atomic force microscopy for cultured bovine endothelial cells exposed to shear stress. J. Biomech. 33: 127-135.
56. Sieminski, A. L., R. P. Hebbel, and K. J. Gooch. 2004. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp. Cell Res. 297: 574-584.
57. Oberleithner, H., C. Riethmuller, H. Schillers, G. A. MacGregor, H. E. de Wardener, and M. Hausberg. 2007. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc. Natl. Acad. Sci. USA. 104: 16281-16286.
58. Jialal, I., and S. Devaraj. 1996. The role of oxidized low density lipoprotein in atherogenesis. J. Nutr. 126: 1053S-1057S.
59. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
60. Colles, S. M., J. M. Maxson, S. G. Carlson, and G. M. Chisolm. 2001. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc. Med. 11: 131-138.
61. Hakamata, H., A. Miyazaki, M. Sakai, H. Matsuda, H. Suzuki, T. Kodama, and S. Horiuchi. 1998. Isolation of macrophage-like cell mutants resistant to the cytotoxic effect of oxidized low density lipoprotein. J. Lipid Res. 39: 482-494.
62. Miller, Y. I., D. S. Worrall, C. D. Funk, J. R. Feramisco, and J. L. Witztum. 2003. Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. Mol. Biol. Cell. 14: 4196-4206
63. Wong, W. T., C. H. Ng, S. Y. Tsang, Y. Huang, and Z. Y. Chen. 2011. Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta. Nutr. Metab. Cardiovasc. Dis. 21: 157-164.
64. Sleer, L. S., A. J. Brown, and E. R. Stanley. 2001. Interaction of caveolin with 7-ketocholesterol. Atherosclerosis. 159: 49-55.
65. Vaya, J., M. Aviram, S. Mahmood, T. Hayek, E. Grenadir, A. Hoffman, and S. Milo. 2001. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic. Res. 34: 485-497.
66. Pereira, T. M., B. V. Nogueira, L. C. Lima, M. L. Porto, J. A. Arruda , E. C. Vasquez, and S. S. Meyrelles. 2010. Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis. 9: 87.
67. Vitale, C., M. E. Mendelsohn, and G. M. Rosano. 2009. Gender differences in the cardiovascular effect of sex hormones. Nat. Rev. Cardiol. 6: 532-542.